ThinkSono
World's first software to diagnose a deadly disease called Deep Vein Thrombosis (DVT).
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor investor | €0.0 | round | |
* | £4.5m | Seed | |
| Total Funding | 000k | ||
Related Content
ThinkSono operates in the healthcare technology sector, specializing in AI-powered ultrasound guidance and training solutions. The company primarily serves non-specialist healthcare professionals, enabling them to perform accurate and efficient ultrasound examinations. ThinkSono's core product, AutoDVT, provides real-time AI annotations that guide users through the process of capturing the correct ultrasound data. This technology is particularly useful for diagnosing Deep Vein Thrombosis (DVT) in primary care settings, reducing the need for specialist equipment and hospital visits.
The business model is subscription-based, offering access to their software and cloud platform where exams can be uploaded for expert feedback and quality assessment. ThinkSono generates revenue through these subscriptions and potentially through partnerships with healthcare institutions.
The market for ThinkSono's solutions includes primary care providers, general practitioners, and healthcare institutions looking to improve diagnostic pathways and patient outcomes. By leveraging AI, ThinkSono aims to democratize access to ultrasound diagnostics, making it easier for non-specialists to perform complex examinations.
Keywords: AI-powered, ultrasound, healthcare, diagnostics, DVT, primary care, non-specialists, training, cloud platform, subscription-based.